
Dr. Protopopescu's presentation highlights how digitalization and artificial intelligence are transforming IVF, enabling more predictable outcomes and data-driven medical decisions.
During the IVF Konferenz, part of the Bucharest Leaders' Summit: A Roadmap to the Future, Dr. Denisa Marina Protopopescu. Her presentation highlighted the growing need for digitalization, standardization, and data-driven approaches in order to reduce variability within laboratory processes.
Drs. Protopopescu explained that many decisions in the IVF laboratory are still influenced by individual experience and visual interpretation. This can lead to variations in embryo assessment and clinical decision making. Modern technologies — from time-lapse systems to integrated software platforms — have the capacity to transform these stages into a more predictable and scientifically grounded process.
A central theme of the presentation focused on how digitalization and automated monitoring help medical teams make more precise, data-driven decisions. Drs. Protopopescu emphasized that technology does not replace the embryologist, but rather provides additional clarity and support.
Klavni elementi includono:
In this way, technology becomes a true ally of the medical team, contributing to the standardization of evaluations.
Intelligencia artificiale ha la abilità di identificare modelli subtístico que o occhio humano pode, offre un opinión secondo objectivo. In her talk, Dr. Protopopescu stressed that AI functions as a partner to the specialist, not as a replacement.
Mentioned benefits include:
This type of analysis provides valuable support in making critical decisions throughout the IVF process.
Drs. Protopopescu also highlighted that the effective use of artificial intelligence is only possible within a laboratory environment supported by well-structured and fully integrated data. At the same time, implementing these technologies must comply with strict ethical standards.
Key principles discussed:
Ethics and responsibility remain top priorities, especially in a field as sensitive as reproductive medicine.
Drs. Denisa Marina Protopopescu's intervention outlined a future in which technology and artificial intelligence play an essential role in improving IVF laboratory processes.
That CMIB, we align with this vision and continue to invest in innovative, scientifically validated solutions to ensure the best possible chances of success in vitro fertilization treatments.